mt1 mt2 antagonists (Millipore)
Structured Review
Mt1 Mt2 Antagonists, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mt1+mt2+antagonists/rabbit+liver+metallothioneins+mt1+mt2/pm34642909-30-3-10
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Melatonin Attenuates Cyclophosphamide-Induced Primordial Follicle Loss by Interaction with MT 1 Receptor and Modulation of PTEN/Akt/FOXO3a Proteins in the Mouse Ovary. Article Snippet: This study evaluated the protective effect of melatonin before cyclophosphamide administration on ovarian function and its potential mechanism in a mouse model. Two studies were performed.. In the first, mice were pretreated with melatonin (10, 20, or 30 mg/kg body weight, i.p.) once daily for 3 days, followed by injection with a single dose of cyclophosphamide (200 mg/ kg body weight, i.p.) 30 min after the last melatonin injection.. The second study analyzed whether melatonin type 1 and/or 2 receptors mediate the effects of melatonin on the ovary through administration of non-selective MT1/MT2 antagonist (luzindole) or selective MT2 antagonist (4-PPDOT) before the treatment with melatonin plus cyclophosphamide. |
![A: When examined on postoperative day 7, the immobility time in the forced swimming test (FST) in WKY rats was significantly improved by melatonin (MT, 4 µg, once daily × 7 days) administered into the ACC contralateral to CCI. The melatonin effect was blocked by the broad MT receptor antagonist <t>luzindole</t> [10 µg but not 5 µg (L10, L5)] injected into the same ACC at 10 min before melatonin (4 µg). *P<0.05, as compared with the sham-vehicle (V) group; ++ P<0.01, as compared with the CCI-vehicle group; ## P<0.01, as compared with the CCI-MT group. B. The same melatonin (MT) treatment also improved the immobility time in the horizontal suspension test (HST) in WKY rat on day 7 after CCI. *P#0.05, as compared with sham and CCI-MT groups.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6964/pmc02386964/pmc02386964__nihms44206f3.jpg)